A Category-II; AIF focused on a sector that forms the backbone of the pharmaceutical, biotechnology and healthcare sectors.

Some of India’s highly visible,
high-growth sectors

depend on an invisible one

Pharma
Engineering

But not one conclusive report on this industry

Anyone can fund growth. Few understand it.

This is The Alanar Way.
We combine capital with deep sector knowledge, practical operating insight, and patient partnership to build companies that endure.

Insight, Not Noise

We operate inside the industries we invest in. Our decisions are shaped by decades of firsthand execution—not market sentiment, cycles, or narratives.

Engineering That Endures

We operate inside the industries we invest in. Our decisions are shaped by decades of firsthand execution—not market sentiment, cycles, or narratives.

Aligned for the Long Run

We operate inside the industries we invest in. Our decisions are shaped by decades of firsthand execution—not market sentiment, cycles, or narratives.

Value Created Through Systems

We operate inside the industries we invest in. Our decisions are shaped by decades of firsthand execution—not market sentiment, cycles, or narratives.

+ OUR TECHNOLOGY

AI-powered insight Technology Icon for disciplined investment in Technology Icon pharmaceutical engineering infrastructure.

An untapped opportunity with immeasurable returns, yet overlooked

Highly Fragmented Industry

Until 3 years ago, collaboration, consolidation, and knowledge sharing were alien concepts in this space

Promoter Fear

Technical geniuses that lack investment knowledge and fear parting with equity in their blood and sweat built companies

Critical Expertise Gap

Small and midsized firms saw potential, but, failed to act, stagnated, or collapsed, clearing the way for rivals to follow

Significant Investor Reluctance

The industry's complexity, the lack of understanding around it, and the absence of a growth-supporting ecosystem, deter investors.

Experience that compounds

Alanar Capital is built on over three decades of hands-on experience across pharmaceutical engineering and allied sectors , and supports growth far beyond spreadsheets.

Built businesses, not just portfolios.

We’ve sat in the founder’s seat, made payroll under pressure, navigated uncertainty, and scaled teams from zero to impact we understand what real execution requires.

Operated through multiple industry cycles.

We’ve seen expansion, contraction, and everything in between. Perspective earned over time informs how we deploy capital and manage risk.

Deep sector experience.

We understand the industries we invest in — their pace, their constraints, and their realities. That clarity allows for better decisions and steadier growth.